SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-13-182053
Filing Date
2013-04-29
Accepted
2013-04-29 16:13:46
Documents
6
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d521027ddefa14a.htm DEFA14A 48843
2 GRAPHIC g521027naa_pg001.jpg GRAPHIC 1191
3 GRAPHIC g521027naa_pg002a.jpg GRAPHIC 2572
4 GRAPHIC g521027naa_pg002b.jpg GRAPHIC 1325
5 GRAPHIC g521027naa_pg003.jpg GRAPHIC 1298
6 GRAPHIC g521027naa_pg004.jpg GRAPHIC 1309
  Complete submission text file 0001193125-13-182053.txt   61211
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21696 | Film No.: 13791796
SIC: 2836 Biological Products, (No Diagnostic Substances)